Efficacy, Safety and Pharmacokinetics Study of CPL207280 After 2-weeks Administration in Subjects With Type 2 Diabetes
Clinical trial NCT05248776 · UNKNOWN
Trial details
- NCT number
- NCT05248776
- Sponsor
- Celon Pharma SA
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-21
- Primary completion
- 2023-06-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.